Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 95659

5 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
November 11, 2024
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Safecor Health, LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

5 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 5

Vitamin D3, 25 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-104-01

D-0056-2025
Recall number
D-0056-2025
Initiated
November 11, 2024
Classification
Class II
Status
Ongoing
Recalling firm
Safecor Health, LLC
Quantity
7488 boxes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Code information

Lot# 24A0052, exp. date 05/01/2026; 24A0057, exp. date 05/13/2026; 24A0066, exp. date 05/31/2026; 24A0067, exp. date 06/04/2026; 24A0068, exp. date 06/17/2026; 24A0069, exp. date 06/19/2026 24A0075, exp. date 07/08/2026 24A0078, exp. date 07/12/2026

Distribution pattern

USA nationwide.

drug · product 2 of 5

Vitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-108-01

D-0057-2025
Recall number
D-0057-2025
Initiated
November 11, 2024
Classification
Class II
Status
Ongoing
Recalling firm
Safecor Health, LLC
Quantity
3139 boxes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Code information

Lot# 24A0050, exp. date 04/25/2026; 24A0055, exp. date 05/09/2026; 24A0059, exp. date 05/16/2026; 24A0060, exp. date 05/20/2026; 24A0071, exp. date 06/24/2026; 24A0072, exp. date 06/26/2026

Distribution pattern

USA nationwide.

drug · product 3 of 5

Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01

D-0058-2025
Recall number
D-0058-2025
Initiated
November 11, 2024
Classification
Class II
Status
Ongoing
Recalling firm
Safecor Health, LLC
Quantity
1470 boxes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Code information

Lot# 24A0061, exp. date 05/23/2026

Distribution pattern

USA nationwide.

drug · product 4 of 5

Calcium Carbonate Chewable 500 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-106-01

D-0059-2025
Recall number
D-0059-2025
Initiated
November 11, 2024
Classification
Class II
Status
Ongoing
Recalling firm
Safecor Health, LLC
Quantity
791 boxes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Code information

Lot# 24A0073, exp. date 06/28/2026

Distribution pattern

USA nationwide.

drug · product 5 of 5

Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01

D-0060-2025
Recall number
D-0060-2025
Initiated
November 11, 2024
Classification
Class II
Status
Ongoing
Recalling firm
Safecor Health, LLC
Quantity
587 boxes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Code information

Lot# 34A0054, exp. date 05/07/2026

Distribution pattern

USA nationwide.

Field note

Send feedback

We'll only use this to respond to your feedback.